Neuroblastoma Parent Symposium will return in 2026 as a virtual webinar series.

The series will take place over six Thursday evenings, starting on 26 February 2026, and continuing through 2 April 2026. Each session will run from 6:00 PM to approximately 7:00 PM (UK time). 

This year’s theme will focus on clinical trials, showcasing the latest developments in current and upcoming neuroblastoma trials across the UK, Europe, and North America. Attendees will hear directly from leading experts about cutting-edge research and treatment options, as well as from patient advocates. Each session will include opportunities to ask questions directly to the speakers. 

Registration is open. FREE

AGENDA (6pm UK local time):

Webinar 1, 26 February | Finding trusted information: navigating the neuroblastoma journey

Webinar 2, 5 March | Understanding current frontline treatment: COG and SIOPEN

Webinar 3, 12 March | BEACON2: Expanding treatment options for relapsed neuroblastoma

Webinar 4, 19 March: The MINT study: addressing unmet need in high-risk neuroblastoma

Webinar 5, 26 March: CAR-T cell therapy: Bambino Gesù Trial and broadening treatment in Europe

Webinar 6, 2 April: Life after treatment: enhancing quality of life for neuroblastoma families